Active Surveillance of Papillary Thyroid Microcarcinoma
1 other identifier
observational
300
1 country
1
Brief Summary
Papillary thyroid microcarcinoma are small thyroid cancer measuring 1cm or less. Most of this tumor are not palpable and are identified either through pathologic examination or from imaging modalities, such as CT scan or thyroid sono. Active surveillance of papillary microcarcinoma is to observe thyroid papillary cancer without immediate surgical approach. The purpose of this study is to understand more about the characteristics of papillary microcarcinoma, which has been known for "the cancer slowly progression"
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2016
CompletedFirst Submitted
Initial submission to the registry
October 31, 2016
CompletedFirst Posted
Study publicly available on registry
November 2, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2021
CompletedNovember 8, 2016
November 1, 2016
1 year
October 31, 2016
November 5, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Progression of papillary thyroid microcarcinoma
Using thyroid sonography, check any changes in size and shape of papillary thyroid microcarcinoma
5 years after enrollment
Eligibility Criteria
This observational study enrolls patients who was diagnosed as papillary thyroid microcarcinoma by FNA (Fine needle aspiration) or CNA(Core needle aspiration) and who wish to be enrolled this study.
You may qualify if:
- \< 1 cm solitary nodule
- Surrounded by ≥ 2 mm normal thyroid parenchyma
- Subcapsular locations not adjacent to surrounding structures, recurrent laryngeal nerve, trachea, or carotid artery
- No evidence of invasion to surrounding structures, recurrent laryngeal nerve, trachea or carotid artery
- No extrathyroidal extension
- Clinically N0 and Clinically M0
- ≥ 18 years
- Combined severe comorbidities or Inoperable condition (optional)
- No wish to surgery and Willingness to accept active surveillance
- No history of radiotherapy on head and neck area
- Accepted by the Board of Thyroid Cancer Meeting
You may not qualify if:
- ≥ 1 cm nodule and multifocal nodules regardless of size
- Papillary thyroid carcinoma variants associated with poor prognosis (tall cell variant, columnar variant, hobnail variant) or other types of thyroid cancer)
- Subcapsular locations adjacent to surrounding structures, recurrent laryngeal nerve, trachea or carotid artery
- Evidence of invasion to surrounding structures, recurrent laryngeal nerve, trachea or carotid artery
- Extrathyroidal extension
- Any of N1 or M1
- Documented increase in size according to America Thyroid Association (ATA) guideline in a previously confirmed Papillary thyroid microcarcinoma
- \< 18 years
- Not willing to accept observational active surveillance approach
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dong Jun Limlead
Study Sites (1)
Seoul St Mary's Hospital
Seoul, Seocho-Gu, 137-701, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Dong-Jun Lim, MD, PhD
Seoul St. Mary's Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 31, 2016
First Posted
November 2, 2016
Study Start
October 1, 2016
Primary Completion
October 1, 2017
Study Completion
October 1, 2021
Last Updated
November 8, 2016
Record last verified: 2016-11
Data Sharing
- IPD Sharing
- Will share